Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Head and Neck Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 136 articles: HTML format

Single Articles

January 2026
1. WU PW, Lee HP, Lin YH
   Curative Surgery Following Induction Chemotherapy for Sinonasal Small Cell Neuroendocrine Carcinoma With Contraindication to Radiotherapy.
   Anticancer Res. 2026;46:539-546.
   PubMed     Abstract available
   
   
   
2. NISHIKAWA T, Higaki A, Mitani S, Higashi H, et al
   Association Between Human Papillomavirus Infection Status and Coronary Artery Calcification in Patients With Oropharyngeal Cancer.
   Anticancer Res. 2026;46:487-491.
   PubMed     Abstract available
   
   
   
3. HUANG YC, Wang CC, Yang C, Li Y, et al
   Protopanaxadiol Induces Apoptosis in NPC/HK1 Human Nasopharyngeal Carcinoma Cells via the Fas/Caspase-8 Signaling Pathway.
   Anticancer Res. 2026;46:195-204.
   PubMed     Abstract available
   
   
   
4. SEKINO N, Murakami K, Toyozumi T, Uesato M, et al
   Clinical Predictors of Neoadjuvant Chemotherapy Efficacy in Esophageal Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:309-318.
   PubMed     Abstract available
   
   
   
5. NAKAMURA S, Kitazawa M, Yamamoto Y, Miyazaki S, et al
   High Incidence of Asymptomatic Pulmonary Embolism Detected on Early Postoperative CT After Thoracoscopic Esophagectomy for Esophageal Cancer: A Prospective Observational Study.
   Anticancer Res. 2026;46:371-383.
   PubMed     Abstract available
   
   
   
6. DAIS P, Papageorgiou K, Mastronikolis N, Papageorgiou GF, et al
   Real-time Capacity Reactance-based Innovative Technology for Detecting Malignant Cells: An Experimental Implementation in Head and Neck Tumors.
   Anticancer Res. 2026;46:237-247.
   PubMed     Abstract available
   
   
   December 2025
7. WANG CC, Hwang TZ, Hsieh MC, Kao TH, et al
   Bis-type Triaziquone Induces PARP1-mediated Cell Death in Human NPC/HK1 Nasopharyngeal Carcinoma Cells.
   Anticancer Res. 2025;45:5457-5464.
   PubMed     Abstract available
   
   
   
8. TAKAHASHI K, Yuda M, Ishikawa Y, Kurogochi T, et al
   Prognostic Significance of Preoperative Peripheral Circulating Eosinophils in Patients who Underwent Esophagectomy for Esophageal Cancer.
   Anticancer Res. 2025;45:5567-5577.
   PubMed     Abstract available
   
   
   November 2025
9. NAKAMURA Y, Nishimura-Yano Y, Nishimura M, Kokubo T, et al
   Spontaneous and Radiation-induced Mammary and Thyroid Tumorigenesis in LEW and (SDxCOP)F(1) Brca1 (L63X/+) Rats.
   Anticancer Res. 2025;45:4869-4880.
   PubMed     Abstract available
   
   
   
10. AOYAMA T, Maezawa Y, Hashimoto I, Yamamoto S, et al
    Body Weight Loss at Recurrence as an Independent Prognostic Factor in Patients With Recurrent Esophageal Cancer After Esophagectomy Who Receive First-line Treatment After Recurrence.
    Anticancer Res. 2025;45:5213-5223.
    PubMed     Abstract available
    
    
    
11. BIZELI ALV, Aquino IG, Cuadra-Zelaya FJM, Palma PVB, et al
    Isolation and Characterization of Putative Cancer Stem Cells from Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2025;45:4803-4815.
    PubMed     Abstract available
    
    
    
12. PAPOULIAKOS S, Chrysovergis A, Papanikolaou V, Tsounis D, et al
    c-MYC Protein Expression Patterns in Laryngeal-Hypopharyngeal Squamous Cell Carcinomas.
    Anticancer Res. 2025;45:4933-4939.
    PubMed     Abstract available
    
    
    
13. MISHIMA K, Matsuda A, Maruyama H, Matsutani T, et al
    Short-term and Long-term Outcomes of Prophylactic Corticosteroid in Esophageal Cancer Surgery: A Multicenter Retrospective Study.
    Anticancer Res. 2025;45:5109-5120.
    PubMed     Abstract available
    
    
    
14. BIRGERSSON M, Chabanova T, Wiechec E, Kostopoulou ON, et al
    Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines.
    Anticancer Res. 2025;45:4729-4742.
    PubMed     Abstract available
    
    
    
15. ASANO Y, Han Q, Li S, Mizuta K, et al
    Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase.
    Anticancer Res. 2025;45:5225-5231.
    PubMed     Abstract available
    
    
    
16. IKAWA H, Shinoto M, Koto M, Hanazawa T, et al
    Long-term Outcomes of Carbon-ion Radiotherapy for Inoperable Locally Advanced Olfactory Neuroblastoma.
    Anticancer Res. 2025;45:5059-5067.
    PubMed     Abstract available
    
    
    October 2025
17. YAMAMOTO E, Kumagai Y, Tachikawa T, Higashi M, et al
    Relationship Between Angiogenesis and Hypoxia-inducible Factor-1alpha and Erythropoietin in Superficial Esophageal Carcinoma.
    Anticancer Res. 2025;45:4201-4209.
    PubMed     Abstract available
    
    
    
18. HONG J, Fan R, Gao Y, Moes G, et al
    Sellar Metastatic Follicular Thyroid Carcinoma With Novel Mutations Clinically Mimicking Pituitary Macroadenoma: Intraoperative Frozen Section Diagnosis Challenges.
    Anticancer Res. 2025;45:4637-4641.
    PubMed     Abstract available
    
    
    
19. YOSHIZAWA M, Miyawaki Y, Sato H, Kawasaki T, et al
    Esophageal Lymphoepithelioma-like Carcinoma With a Remarkable Response to DCF Chemotherapy: A Case Report.
    Anticancer Res. 2025;45:4643-4652.
    PubMed     Abstract available
    
    
    
20. MAKIYAMA T, Matsumoto Y, Toyozumi T, Nakano A, et al
    Clinical Significance of Molar Count in Esophageal Squamous Cell Carcinoma: Propensity Score Matching Study.
    Anticancer Res. 2025;45:4597-4606.
    PubMed     Abstract available
    
    
    
21. HSU SW, Hsu CL, Shih HY, Chen KY, et al
    Elucidating the Genetic Contribution to Nasopharyngeal Carcinoma Risk Through Matrix Metalloproteinase-11 (MMP-11) Genotypic Analysis.
    Anticancer Res. 2025;45:4181-4192.
    PubMed     Abstract available
    
    
    September 2025
22. AMANO Y, Matsubara D, Kihara A, Yoshimoto T, et al
    The Significance of Phosphorylated Yes-associated Protein (YAP) (Ser 127) Expression in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2025;45:3835-3845.
    PubMed     Abstract available
    
    
    
23. SATO F, Ono T, Hiraki A, Oka T, et al
    Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent omicronr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab.
    Anticancer Res. 2025;45:3993-4004.
    PubMed     Abstract available
    
    
    
24. HIROTA J, Takeda D, Sadakane Y, Matsuzoe Y, et al
    TGF-B-induced Cancer-associated Fibroblast Activation Promotes Tumor Progression In Oral Squamous Cell Carcinoma Mouse Model.
    Anticancer Res. 2025;45:3687-3700.
    PubMed     Abstract available
    
    
    
25. SUZUKI H, Taniguchi H, Inaba Y, Tachibana H, et al
    Survival Outcome for Peptide Receptor Radionuclide Therapy in Olfactory Neuroblastoma.
    Anticancer Res. 2025;45:3877-3884.
    PubMed     Abstract available
    
    
    
26. ANZELLINI D, Loddo M, Del Bianco S
    Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2025;45:3809-3816.
    PubMed     Abstract available
    
    
    
27. YANG TL, Chen PH, Lee HL, Jhou HJ, et al
    Tegafur-uracil as a Maintenance Therapy for Non-metastatic Nasopharyngeal Carcinoma: Insights from the Literature.
    Anticancer Res. 2025;45:3617-3628.
    PubMed     Abstract available
    
    
    August 2025
28. TERATANI Y, Sadanaga T, Wang S, Kusukawa J, et al
    Nuclear Localization of Chitinase 3-like 1 Is a Novel Biomarker for Detecting the Early Stage of Inflammation-associated Dysplasia in the Oral Cavity.
    Anticancer Res. 2025;45:3469-3478.
    PubMed     Abstract available
    
    
    
29. FUJIYOSHI K, Sugihara R, Miyamoto N, Watanabe Y, et al
    Comparison of Comprehensive Genomic Profiling Testing "Ion Torrent Genexus Sequencer" With FoundationOne.
    Anticancer Res. 2025;45:3479-3486.
    PubMed     Abstract available
    
    
    
30. TAKIMOTO R, Kamigaki T, Okada S, Ibe H, et al
    Clinical Evaluation of Immune Cell Therapy in Esophageal Cancer Resistant to Immunochemotherapy.
    Anticancer Res. 2025;45:3553-3559.
    PubMed     Abstract available
    
    
    
31. KIMURA S, Aoki M, Nishi K, Takeuchi T, et al
    CD155 Expression Predicts Poor Prognosis in OTSCC and Correlates With TIGIT Expression and Tumor Budding.
    Anticancer Res. 2025;45:3511-3522.
    PubMed     Abstract available
    
    
    
32. AOYAMA T, Maezawa Y, Hashimoto I, Kazama K, et al
    The C-reactive Protein to Albumin Ratio (CAR) Is an Independent Prognostic Factor for Recurrence in Patients With Esophageal Cancer After Esophagectomy.
    Anticancer Res. 2025;45:3365-3372.
    PubMed     Abstract available
    
    
    
33. FUJIWARA K, Mukohyama J, Kato F, Kato A, et al
    Late-onset Colonic Graft and Overlying Skin Necrosis 15 Years After Esophagectomy and Gastrectomy: A Case Report.
    Anticancer Res. 2025;45:3561-3566.
    PubMed     Abstract available
    
    
    July 2025
34. LI Y, Huang BM, Tao CC, Lan YY, et al
    Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Cisplatin-induced Apoptotic Effects via the ROS-Fas Pathway in Human NPC-TW01 Nasopharyngeal Carcinoma Cells.
    Anticancer Res. 2025;45:3117-3126.
    PubMed     Abstract available
    
    
    
35. HSU CC, Huang BM, Wu YT, Wang CC, et al
    Bis-type Triaziquone Induces Apoptotic Effects in Human OEC-M1 Oral Cancer Cells.
    Anticancer Res. 2025;45:3069-3075.
    PubMed     Abstract available
    
    
    
36. WIZIACK ZAGO PM, Hellmeister LR, Teixeira LN, DE Brito Junior RB, et al
    Cytotoxic and Metalloproteinase-inhibitory Effects of Ellagic Acid Against Oral Squamous Cell Carcinoma.
    Anticancer Res. 2025;45:2871-2880.
    PubMed     Abstract available
    
    
    
37. WON S, Hah YS, Cheon SY, Yim CD, et al
    Periostin Promotes Invasiveness and Metastasis of Oral Cancer via Epithelial-mesenchymal Transition.
    Anticancer Res. 2025;45:3099-3115.
    PubMed     Abstract available
    
    
    June 2025
38. PAPOULIAKOS S, Papanikolaou V, Chrysovergis A, Tsiambas E, et al
    C-myc Oncogene Numerical Imbalances Analysis in Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2025;45:2377-2383.
    PubMed     Abstract available
    
    
    
39. BASKAR S, Schoeneich R, Grewal US
    In-hospital Outcomes Between Total Parenteral Nutrition and Enteral Feeding in Esophageal and Gastric Cancer: A Nationwide Analysis.
    Anticancer Res. 2025;45:2453-2457.
    PubMed     Abstract available
    
    
    
40. CHEN KY, Hsu CL, Hsu SW, Liu YF, et al
    Association of Interleukin-12A Genotypes With Nasopharyngeal Carcinoma Risk.
    Anticancer Res. 2025;45:2297-2308.
    PubMed     Abstract available
    
    
    
41. DUAH E, Poi M, Li J
    Trametinib Synergized With Abemaciclib to Inhibit Tumor Growth in Human Head and Neck Squamous Cell Carcinoma Cells.
    Anticancer Res. 2025;45:2285-2295.
    PubMed     Abstract available
    
    
    
42. KANEMITSU K, Tagayasu Y, Yamada R, Iwatsuki M, et al
    A Case of Complete Response to ICI Therapy for Unresectable Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2025;45:2689-2695.
    PubMed     Abstract available
    
    
    May 2025
43. LAI KC, Chen CW, Chang PM, Liao YC, et al
    Correlation Analysis Between IFIT2 and HLA Class II in Oral Cancer.
    Anticancer Res. 2025;45:1897-1914.
    PubMed     Abstract available
    
    
    
44. YAMAGISHI S, Kanda M, Shinozuka T, Sato Y, et al
    High Expression of OR1F1 Protein as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2025;45:1997-2009.
    PubMed     Abstract available
    
    
    
45. YAMASHITA T, Fujimasa K, Otsuka K, Saito A, et al
    Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine Carcinoma.
    Anticancer Res. 2025;45:2051-2058.
    PubMed     Abstract available
    
    
    
46. LAI LW, Yamashita T, Otsuka K, Saito A, et al
    Rare Upper Mediastinal Oligometastasis from Early Esophagogastric Adenocarcinoma: A Case Report.
    Anticancer Res. 2025;45:2109-2114.
    PubMed     Abstract available
    
    
    
47. KITADANI J, Hayata K, Goda T, Tominaga S, et al
    The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy.
    Anticancer Res. 2025;45:2225-2235.
    PubMed     Abstract available
    
    
    April 2025
48. HAYASHI K, Ishida K, Kato M, Ohkubo S, et al
    Activation of DCTN1-RET Fusion Through Coiled-coil Domain as a Potential Target for RET Inhibitors.
    Anticancer Res. 2025;45:1407-1417.
    PubMed     Abstract available
    
    
    
49. OUCHI T, Morikawa S, Nakagawa T, Asoda S, et al
    Platelet-derived Growth Factor Receptor-alpha as a Biomarker for Tongue Spindle Cell Carcinoma.
    Anticancer Res. 2025;45:1387-1393.
    PubMed     Abstract available
    
    
    
50. HIRAKI Y, Masuda T, Motomura Y, Tobo T, et al
    Programmed Cell Death 10 (PDCD10) Is a Candidate Tumor-associated Gene in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2025;45:1419-1433.
    PubMed     Abstract available
    
    
    March 2025
51. MA Y, Qian L, Wang D, Chen C, et al
    LncRNA XIST Promotes Proliferation, Migration and Invasion of Esophageal Squamous Cell Carcinoma Cells via Regulation of miR-186-5p/ZEB1.
    Anticancer Res. 2025;45:897-908.
    PubMed     Abstract available
    
    
    
52. IGLESIAS L, Vilchez R, Aguin S, Garcia R, et al
    Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study.
    Anticancer Res. 2025;45:1181-1191.
    PubMed     Abstract available
    
    
    
53. FLECKNER J, Idel C, Leichtle A, Steffen A, et al
    Elevated Plasma Interleukin-18 Levels in Head and Neck Squamous Cell Carcinoma: Correlation With IL-18 Binding Protein But Not Ferritin.
    Anticancer Res. 2025;45:943-954.
    PubMed     Abstract available
    
    
    
54. JUNG EK, Kim SA, Salam SMA, Lee KH, et al
    Role of Keratin-10 in Tumor Progression and Radioresistance of Laryngeal Cancer Cells.
    Anticancer Res. 2025;45:1035-1045.
    PubMed     Abstract available
    
    
    
55. AOKI K, Yoshitani N, Kurio N, Yoshioka N, et al
    Angiogenin-induced Osteoclastogenesis Mediates Bone Destruction in Oral Squamous Carcinoma.
    Anticancer Res. 2025;45:1025-1033.
    PubMed     Abstract available
    
    
    February 2025
56. GLITZKY S, Franzen A, Coordes A
    The Impact of Tonsillectomy on Oropharyngeal Cancer Development.
    Anticancer Res. 2025;45:709-718.
    PubMed     Abstract available
    
    
    
57. NONAKA Y, Baba T, Sugita S, Miyata K, et al
    Negative Impact of High FOXP3 Status in Lymph Nodes of Esophageal Squamous Cell Carcinoma Patients.
    Anticancer Res. 2025;45:781-787.
    PubMed     Abstract available
    
    
    January 2025
58. SUGIYAMA N, Yamada S, Nakamura Y, Morita K, et al
    Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck.
    Anticancer Res. 2025;45:81-95.
    PubMed     Abstract available
    
    
    
59. HIROTAKI K, Moriya S, Tomizawa K, Wakabayashi M, et al
    Prediction and Monitoring of Adaptive Radiation Therapy Timing Using Two-dimensional X-ray Image-based Water Equivalent Thickness.
    Anticancer Res. 2025;45:387-397.
    PubMed     Abstract available
    
    
    December 2024
60. BOWERS JC, Savaliya BP, Raikot SR, Ahmed SH, et al
    Survival Outcomes and Disparities in Surgery Refusal for Papillary Thyroid Cancer.
    Anticancer Res. 2024;44:5455-5461.
    PubMed     Abstract available
    
    
    
61. TORIGOE R, Oshikiri T, Goto H, Koterazawa Y, et al
    Prognostic Impact of Squamous Cell Carcinoma Antigen During Neoadjuvant Chemotherapy for Patients With Esophageal Squamous Cell Carcinoma Treated With Minimally Invasive Esophagectomy.
    Anticancer Res. 2024;44:5485-5493.
    PubMed     Abstract available
    
    
    
62. KIM D, Park YJ, Hwang YS
    Regulation of Tumor Growth and Invasion in Oral Squamous Cell Carcinoma by the Tumor Microenvironment Through the Enhancement of IGFBP-3 Expression.
    Anticancer Res. 2024;44:5337-5349.
    PubMed     Abstract available
    
    
    
63. IKAWA H, Koto M, Omatsu T, Aoki S, et al
    Prognostic Factors of Flap Complications After Carbon-ion Radiotherapy for Head and Neck Cancer With Reconstruction.
    Anticancer Res. 2024;44:5569-5576.
    PubMed     Abstract available
    
    
    
64. VASUDEVAN HN, Lazar AA, Reyes K, Rong DA, et al
    Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein-Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma.
    Anticancer Res. 2024;44:5445-5453.
    PubMed     Abstract available
    
    
    November 2024
65. ESASHI R, Aoyama T, Maezawa Y, Hashimoto I, et al
    The Clinical Impact of the Systemic Immune-inflammation Index in Esophageal Cancer Patients Receiving Curative Treatment.
    Anticancer Res. 2024;44:5035-5041.
    PubMed     Abstract available
    
    
    
66. MIYASAKA Y, Kusano Y, Mizoguchi N, Takayama Y, et al
    Development of a Tumor Growth-responsive Robust Planning Method for Head and Neck Cancer in Carbon-ion Radiotherapy.
    Anticancer Res. 2024;44:5113-5122.
    PubMed     Abstract available
    
    
    October 2024
67. MIYAKE R, Takeyama H, Manome Y, Koyama M, et al
    Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression.
    Anticancer Res. 2024;44:4561-4568.
    PubMed     Abstract available
    
    
    
68. NA YM, Park SC, An SY, Ma HU, et al
    Analysis of Initial Outcomes of Gas-insufflation One-step Single-port Transaxillary (GOSTA) Robotic Thyroidectomy for Thyroid Cancer.
    Anticancer Res. 2024;44:4585-4592.
    PubMed     Abstract available
    
    
    
69. KUGA R, Hashimoto K, Yamamoto H, Taniguchi M, et al
    Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy.
    Anticancer Res. 2024;44:4593-4603.
    PubMed     Abstract available
    
    
    
70. XU L, Tian A, Fan R, Lai J, et al
    Synchronous Pancreatic Ductal Adenocarcinoma and Nasopharyngeal Carcinoma With Associated Novel Pathogenic ATM Mutation.
    Anticancer Res. 2024;44:4605-4608.
    PubMed     Abstract available
    
    
    September 2024
71. SATO M, Sato T, Hozumi C, Han Q, et al
    [(11)C]Methionine PET vs. [(18)F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.
    Anticancer Res. 2024;44:3891-3898.
    PubMed     Abstract available
    
    
    
72. HAGIWARA K, Matsuki T, Okada T, Fushimi C, et al
    Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab.
    Anticancer Res. 2024;44:4057-4072.
    PubMed     Abstract available
    
    
    
73. MATSUMURA S, Kaira K, Kuba K, Inoue H, et al
    Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:4049-4056.
    PubMed     Abstract available
    
    
    
74. HIRAKAWA H, Ikegami T, Kinjyo H, Hayashi Y, et al
    Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer.
    Anticancer Res. 2024;44:3907-3912.
    PubMed     Abstract available
    
    
    
75. FUJII S, Okamoto I, Okada T, Tokashiki K, et al
    Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer.
    Anticancer Res. 2024;44:4085-4092.
    PubMed     Abstract available
    
    
    
76. CHEN CH, Chin YT, Hsu SW, Shih LC, et al
    Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk.
    Anticancer Res. 2024;44:3813-3820.
    PubMed     Abstract available
    
    
    
77. MATSUDA H, Iwahori K, Takeoka T, Kato R, et al
    Helicobacter pylori Infection Affects the Tumor Immune Microenvironment of Esophageal Cancer Patients.
    Anticancer Res. 2024;44:3799-3805.
    PubMed     Abstract available
    
    
    August 2024
78. HIRASAWA Y, Kubota Y, Mura E, Suzuki R, et al
    Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment.
    Anticancer Res. 2024;44:3397-3407.
    PubMed     Abstract available
    
    
    
79. RACINE F, Louandre C, Demagny J, Godin C, et al
    Transcriptional Induction of SERPINE1 and Fibrinolysis Inhibition as Predominant Effects of Glucocorticoids on the Cancer Coagulome.
    Anticancer Res. 2024;44:3269-3276.
    PubMed     Abstract available
    
    
    
80. WU J, Chun C, Lagunas AM, Crowe DL, et al
    Lysine Methyltransferase 2D Regulates Immune Response and Metastasis in Head and Neck Cancer.
    Anticancer Res. 2024;44:3231-3242.
    PubMed     Abstract available
    
    
    
81. HUBER L, Knuttel MT, Kramer B, Zaubitzer L, et al
    Influence of Tyrosine Kinase Inhibitors and Everolimus on TGFbeta1 and TGF-beta Receptor 2 in Squamous Cell Carcinoma Cells.
    Anticancer Res. 2024;44:3287-3294.
    PubMed     Abstract available
    
    
    
82. GAO A, Kim DW, Pei M, Kim KY, et al
    Implications of TP-positive CAFs in the Bone Invasion of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:3365-3374.
    PubMed     Abstract available
    
    
    July 2024
83. CHIKAMATSU K, Ida S, Masuda K, Horikawa M, et al
    Enhancement of Tumor Antigen-specific T-cell Responses by Immune Checkpoint Blockade in Human Papillomavirus-related Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:2921-2931.
    PubMed     Abstract available
    
    
    
84. TODA S, Saito N, Kadoya M, Okubo Y, et al
    Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.
    Anticancer Res. 2024;44:3141-3147.
    PubMed     Abstract available
    
    
    
85. GEISTHOFF UW, Droege F, Hand C, Holtmann LC, et al
    Clinical Value of Fine Needle Aspiration Cytology and Core Needle Biopsy in Head and Neck Pathology - A Nationwide Survey in Germany.
    Anticancer Res. 2024;44:3115-3124.
    PubMed     Abstract available
    
    
    
86. SUZUKI G, Yamazaki H, Aibe N, Masui K, et al
    Optimizing Therapeutic Approaches in Superficial Esophageal Cancer: Reduced-volume Radiotherapy and Dose-dense Chemotherapy After Endoscopic Resection.
    Anticancer Res. 2024;44:3133-3139.
    PubMed     Abstract available
    
    
    June 2024
87. KRUGER K, Grust A, Muallah D, Patenge A, et al
    PIK3CA Hotspot Mutations in Saliva as a Diagnostic Marker in Oral Squamous Cell Carcinoma Patients.
    Anticancer Res. 2024;44:2369-2376.
    PubMed     Abstract available
    
    
    
88. TAI CH, Wang CC, Shih YC, Chen YJ, et al
    Functional Role of DUSP6 in the EGFR-mediated Progression of Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:2545-2554.
    PubMed     Abstract available
    
    
    
89. LIN CH, Chiang CC, Shih YC, Tung SL, et al
    Elucidating the Role of Let-7d-5p and OLR1 in the Progression and Prognosis of Oral Squamous Cell Carcinoma via FAK/P53 Signaling Axis.
    Anticancer Res. 2024;44:2517-2531.
    PubMed     Abstract available
    
    
    
90. HUJANEN R, Salo T, Eklund KK, Salem A, et al
    Ex Vivo Evaluation of Antiangiogenic Drugs in Oral Cancer: Potential Implications for Targeting Vasculogenic Mimicry.
    Anticancer Res. 2024;44:2377-2392.
    PubMed     Abstract available
    
    
    May 2024
91. LUKOCEVICIUTE M, Zupancic M, Kostopoulou ON, Holzhauser S, et al
    Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status.
    Anticancer Res. 2024;44:1863-1876.
    PubMed     Abstract available
    
    
    
92. ICHIKAWA H, Ishikawa T, Sugai M, Muneoka Y, et al
    Prognostic Significance of NQO1 Expression in Non-neoplastic Esophageal Squamous Epithelium for Patients With Esophageal Cancer.
    Anticancer Res. 2024;44:1915-1924.
    PubMed     Abstract available
    
    
    
93. AOYAMA T, Hashimoto I, Maezawa Y, Hara K, et al
    The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment.
    Anticancer Res. 2024;44:2185-2192.
    PubMed     Abstract available
    
    
    
94. SAMUKAWA Y, Ouchi Y, Miyashita T, Rahman A, et al
    Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation.
    Anticancer Res. 2024;44:1895-1903.
    PubMed     Abstract available
    
    
    April 2024
95. KIM SI, Lee JW, Eun YG, Lee YC, et al
    Utilizing the AJCC 8(th) Staging to Discriminate Survival Outcomes in HPV-associated Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:1703-1710.
    PubMed     Abstract available
    
    
    
96. TANAKA Y, Sato Y, Horaguchi T, Fujibayashi S, et al
    Radiomics Features Using Dual-energy CT for Lymph Nodes After Preoperative Chemotherapy for Esophageal Cancer.
    Anticancer Res. 2024;44:1661-1674.
    PubMed     Abstract available
    
    
    
97. ZUPANCIC M, Nasman A, Friesland S, Dalianis T, et al
    Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies.
    Anticancer Res. 2024;44:1325-1334.
    PubMed     Abstract available
    
    
    
98. NOH MH, Kim HY, Kim DH, Moon SH, et al
    Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma.
    Anticancer Res. 2024;44:1425-1440.
    PubMed     Abstract available
    
    
    
99. YAMAGUCHI T, Okamoto K, Saito H, Shimada M, et al
    Impact of Arteriosclerosis on Reconstruction-related Complications After Esophagectomy and Usefulness of Tailor-made Reconstruction Technique.
    Anticancer Res. 2024;44:1719-1726.
    PubMed     Abstract available
    
    
    March 2024
100. KODAMA H, Kadowaki S, Nakazawa T, Matsubara Y, et al
     Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study.
     Anticancer Res. 2024;44:1227-1232.
     PubMed     Abstract available
     
     
     
101. EDEN D, Ghose A, Moschetta M, Perez-Fidalgo JA, et al
     Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysis.
     Anticancer Res. 2024;44:861-878.
     PubMed     Abstract available
     
     
     
102. SOHDA M, Hara K, Kuriyama K, Tateno K, et al
     Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer.
     Anticancer Res. 2024;44:1309-1315.
     PubMed     Abstract available
     
     
     
103. BAUDREXL J, Sakkas A, Pietzka S, Derka S, et al
     Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study.
     Anticancer Res. 2024;44:1247-1270.
     PubMed     Abstract available
     
     
     
104. CHEN PH, Lu HK, Renn TY, Chang TM, et al
     Plumbagin Induces Reactive Oxygen Species and Endoplasmic Reticulum Stress-related Cell Apoptosis in Human Oral Squamous Cell Carcinoma.
     Anticancer Res. 2024;44:1173-1182.
     PubMed     Abstract available
     
     
     
105. MACHIDA T, Sakuma K, Fuwa N, Tanaka A, et al
     Local Low-dose Anti-PD-L1 Antibodies Improve Antitumor Effects in Oral Squamous Cell Carcinoma.
     Anticancer Res. 2024;44:993-1002.
     PubMed     Abstract available
     
     
     February 2024
106. AOYAMA T, Hashimoto I, Maezawa Y, Hara K, et al
     CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
     Anticancer Res. 2024;44:815-822.
     PubMed     Abstract available
     
     
     
107. ZOU X, Lin Y, Ren H, Meng Y, et al
     PRMT5-PAK1 Signaling Participates in Metastasis and Is Associated With Poor Prognosis in Human Esophageal Carcinoma.
     Anticancer Res. 2024;44:593-604.
     PubMed     Abstract available
     
     
     
108. HERAMB-AAMOT J, Mala T, Fauske L
     Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study.
     Anticancer Res. 2024;44:743-750.
     PubMed     Abstract available
     
     
     January 2024
109. AOYAMA T, Kato A, Maezawa Y, Hashimoto I, et al
     Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
     Anticancer Res. 2024;44:339-346.
     PubMed     Abstract available
     
     
     
110. BAUDREXL J, Pietzka S, Scheurer M, Schramm A, et al
     Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer.
     Anticancer Res. 2024;44:267-286.
     PubMed     Abstract available
     
     
     
111. LEE S, Fujiwara Y, Gyobu K, Tamura T, et al
     Evaluation of Intraoperative Neural Monitoring During Thoracoscopic Surgery for Esophageal Cancer.
     Anticancer Res. 2024;44:157-166.
     PubMed     Abstract available
     
     
     
112. AOYAMA T, Kato A, Hashimoto I, Maezawa Y, et al
     Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
     Anticancer Res. 2024;44:249-255.
     PubMed     Abstract available
     
     
     
113. KATO A, Aoyama T, Maezawa Y, Hashimoto I, et al
     Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
     Anticancer Res. 2024;44:331-337.
     PubMed     Abstract available
     
     
     
114. TSUCHIDA K, Shiga K, Katagiri K, Saito D, et al
     Increasing Patients With HPV-positive Oropharyngeal Squamous Cell Carcinoma and its Oncologic Outcomes in the Rural Region in Northern Japan.
     Anticancer Res. 2024;44:403-407.
     PubMed     Abstract available
     
     
     
115. YOSHIMURA N, Fujiwara M, Igeta M, Suzuki H, et al
     Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB-VMAT.
     Anticancer Res. 2024;44:323-329.
     PubMed     Abstract available
     
     
     
116. SUGASE T, Kanemura T, Takeoka T, Matsuura N, et al
     Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma.
     Anticancer Res. 2024;44:185-193.
     PubMed     Abstract available
     
     
     
117. EBELING M, Derka S, Baudrexl J, Sakkas A, et al
     Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy - A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients.
     Anticancer Res. 2024;44:313-322.
     PubMed     Abstract available
     
     
     December 2023
118. ASANUMA K, Ishihara M, Nakamura T, Uchida K, et al
     Histological Assessment of Synovial Sarcoma Before and After TCR-T Cell Therapy and Cryoablation: A Case Report.
     Anticancer Res. 2023;43:5737-5748.
     PubMed     Abstract available
     
     
     
119. SUZUKI H, Haimoto S, Inaba Y, Tachibana H, et al
     Peptide Receptor Radionuclide Therapy for Recurrent Olfactory Neuroblastoma After Cranioplasty for Surgical Infection: A Case Report.
     Anticancer Res. 2023;43:5723-5728.
     PubMed     Abstract available
     
     
     
120. SAMARA W, Moztarzadeh O, Pernicky J, Baghalipour N, et al
     Carotid Artery Stenosis on Panoramic Radiographs and CT Scans in Patients With Malignancies After Radiotherapy.
     Anticancer Res. 2023;43:5657-5662.
     PubMed     Abstract available
     
     
     
121. IDEL C, Ribbat-Idel J, VON Bernuth A, Fleckner J, et al
     Correlation of Intra-tumoral and Peripheral PD-1/PD-L1 Immunity in Head and Neck Cancer.
     Anticancer Res. 2023;43:5349-5358.
     PubMed     Abstract available
     
     
     
122. BURYSKA S, Patel K, Wuertz B, Gaffney PM, et al
     Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality.
     Anticancer Res. 2023;43:5299-5310.
     PubMed     Abstract available
     
     
     November 2023
123. HSU CC, Wu YT, Yu SJ, Chen PJ, et al
     NAD(P)H:quinone Oxidoreductase 1 Is Involved in AZ-1-induced Apoptotic Effects in Nasopharyngeal Carcinoma TW01 Cells.
     Anticancer Res. 2023;43:4879-4885.
     PubMed     Abstract available
     
     
     
124. WATANABE H, Kano K, Hashimoto I, Tanabe M, et al
     Intraoperative Blood Loss Impacts Recurrence and Survival in Patients With Locally Advanced Esophageal Cancer.
     Anticancer Res. 2023;43:5173-5179.
     PubMed     Abstract available
     
     
     
125. NATSUKI S, Miki Y, Tanaka H, Nishiyama M, et al
     Usefulness of Biopsy Specimens for Evaluating CD103(+) Tumor-resident Memory T Cells in Esophageal Cancer.
     Anticancer Res. 2023;43:4823-4832.
     PubMed     Abstract available
     
     
     
126. FUKUSHIMA H, Naruse T, Furukawa K, Omori K, et al
     Extranodal Extension and Epithelial Cell Adhesion Molecule Over-expression in Oral Squamous Cell Carcinoma.
     Anticancer Res. 2023;43:5155-5166.
     PubMed     Abstract available
     
     
     
127. CHEN H, Pei M, Shin SW, Moon S, et al
     Implication of TIPE2 Expression on the Malignant Transformation of Oral Leukoplakia.
     Anticancer Res. 2023;43:4937-4946.
     PubMed     Abstract available
     
     
     
128. ISHIDA Y, Shintani T, Nobumoto T, Sakurai S, et al
     Interaction of Integrin alphavbeta8 With Type I Collagen Promotes Squamous Cell Carcinoma Cell Motility via RAC1 Activation.
     Anticancer Res. 2023;43:4833-4841.
     PubMed     Abstract available
     
     
     
129. KOWKABANY G, Jimenez PB, Sharan S, Bansal S, et al
     Inequities in Time to Treat Thyroid Cancer.
     Anticancer Res. 2023;43:5025-5030.
     PubMed     Abstract available
     
     
     
130. KANEMOTO H, Obata K, Umemori K, Hasegawa K, et al
     Multimodal Prediction of Cervical Lymph Node Metastasis and Recurrence in Oral Squamous Cell Carcinoma.
     Anticancer Res. 2023;43:4993-5001.
     PubMed     Abstract available
     
     
     
131. ASAKA S, Shimakawa T, Nishiguchi R, Yamaguchi K, et al
     Preoperative and Postoperative C-Reactive Protein to Albumin Ratio (CAR) as a Prognostic Marker for Survival of Esophageal Squamous Cell Carcinoma Patients After Surgery.
     Anticancer Res. 2023;43:5139-5147.
     PubMed     Abstract available
     
     
     October 2023
132. ZHOU J, Liu J, Zhang KE, Lv J, et al
     High-throughput Sequencing Analysis of Differentially Expressed microRNAs Associated With SREBP1 in Differentiated Thyroid Carcinoma.
     Anticancer Res. 2023;43:4435-4446.
     PubMed     Abstract available
     
     
     
133. DURZYNSKA M, Dos Santos FLC, Michalek IM
     Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study.
     Anticancer Res. 2023;43:4517-4524.
     PubMed     Abstract available
     
     
     
134. DURZYNSKA M, Dos Santos FLC, Matuszczyk A, Derezinska-Wolek E, et al
     Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases.
     Anticancer Res. 2023;43:4551-4557.
     PubMed     Abstract available
     
     
     
135. TAKEHARA Y, Tamaki T, Mimura K, Saito K, et al
     Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma.
     Anticancer Res. 2023;43:4691-4700.
     PubMed     Abstract available
     
     
     
136. DUMITRU CS, Raica M
     Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma.
     Anticancer Res. 2023;43:4315-4326.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.